ProfileGDS5822 / ILMN_1239717
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 80% 93% 85% 77% 87% 79% 83% 91% 93% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 1133.180
GSM1276600PDAC Late Ablation Control 2735.693
GSM1276601PDAC Late Ablation Control 3345.685
GSM1276602PDAC Late Ablation 1102.377
GSM1276603PDAC Late Ablation 2345.387
GSM1276604PDAC Late Ablation 313479
GSM1303940PDAC Late Ablation_anti-CTLA4 1187.583
GSM1303941PDAC Late Ablation_anti-CTLA4 2709.991
GSM1303942PDAC Late Ablation_anti-CTLA4 3969.593